Islet Sciences Announces DiaKine Therapeutics, Inc.' Novel Diabetes, Atherosclerosis Drugs Receives European Patent Protection
3/30/2012 9:22:49 AM
More...
|
Islet Sciences Announces Closing of Islet Sciences Acquisition
3/23/2012 6:33:12 AM
More...
|
Islet Sciences Enters Into Agreement to Acquire DiaKine Therapeutics, Inc.
2/29/2012 2:47:35 PM
More...
|
DiaKine Therapeutics, Inc. Named a Top Innovator by youngStartup Ventures
12/8/2009 10:06:28 AM
More...
|
DiaKine Therapeutics, Inc. Diabetes Immune Modulator Drug Set for Human Clinical Trial
5/12/2009 11:04:40 AM
More...
|
DiaKine Therapeutics, Inc. Drug Improves Type 2 Insulin Action; Reduces Harm of Fat in Preclinical Study
1/22/2009 9:11:35 AM
More...
|
DiaKine Therapeutics, Inc.'s Lead Compound in Phase 2 Clinical Trial
10/14/2008 11:09:44 AM
More...
|
DiaKine Therapeutics, Inc. and Kinexum Metabolics, Inc. to Develop Novel Combination Treatment to Type 1 Diabetes
5/6/2008 8:53:01 AM
More...
|
DiaKine Therapeutics, Inc. Release: Combination Drug Therapy May Hold the Key to Reversing Type 1 Diabetes
4/8/2008 8:42:13 AM
More...
|
DiaKine Therapeutics, Inc. to Be Awarded Patent for Restoring Insulin Producing Cell Function in Diabetics
4/1/2008 9:01:00 AM
More...
|
|